Open Access

Erratum to: Increased copy number at 3p14 in breast cancer

  • Ingrid Ljuslinder1Email author,
  • Beatrice Malmer1,
  • Irina Golovleva2,
  • Marcus Thomasson1,
  • Kjell Grankvist3,
  • Thomas Höckenström4,
  • Stefan Emdin5,
  • Yvonne Jonsson1,
  • Håkan Hedman1 and
  • Roger Henriksson1
Breast Cancer Research20068:405

https://doi.org/10.1186/bcr1409

Published: 4 April 2006

The original article was published in Breast Cancer Research 2005 7:R719

It was recently noticed that an error had been made in the research article by Ljuslinder and colleagues [1] published by Breast Cancer Research in July 2005. The legend of Table 4 was incorrect and should read as featured opposite.
Table 4

EGFR and ERBB2 quantitative RT-PCR mRNA results in eight patients and matched controls (group B)

Patient number

T

NN

T/NNa

1b

   

   EGFR

4,677

12,493

0.37

   ERBB2

24,066

21,817

1.1

2b

   

   EGFR

3,321

14,519

0.22

   ERBB2

61,389

6,666

9.2

4

   

   EGFR

20,778

14,842

1.39

   ERBB2

9,143

6,742

1.35

5b

   

   EGFR

9,730

15,867

0.61

   ERBB2

13,506

3,056

4.41

6

   

   EGFR

1,305

15,871

0.08

   ERBB2

10,677

10,080

1.06

7

   

   EGFR

1,024

12,162

0.08

   ERBB2

7,639

5,871

1.30

8b

   

   EGFR

4,936

28,111

0.17

   ERBB2

17,106

9,263

1.85

9

   

   EGFR

5,540

1,437

3.85

   ERBB2

7,330

5,540

1.32

aT/NN: mRNA expression levels of EGFR/ERBB2 in tumour tissue (T) samples divided by values in in matched non-neoplastic (NN) tissue samples. As described in the results, at p.9, ratios > 1. 2 are regarded as significant overexpression and ratios < 0. 8 are regarded as significant underexpression in neoplastic tissue compared to non-neoplastic tissue. bPatients with increased LRIG1 copy number. No RNA from patient 3 was available for EGFR/ERBB2 analysis.

Notes

Authors’ Affiliations

(1)
Department of Radiation Sciences, Oncology, Umeå University
(2)
Department of Medical Biosciences, Medical and Clinical Genetics
(3)
Department of Medical Biosciences, Clinical Chemistry, Umeå University
(4)
Department of Pathology, Umeå University
(5)
Department of Surgical and Perioperative Sciences, Division of Surgery, Umeå University

References

  1. Ljuslinder I, Malmer B, Golovleva I, Thomasson M, Grankvist K, Höckenström T, Emdin S, Jonsson Y, Hedman H, Henriksson R: Increased copy number at 3p14 in breast cancer. Breast Cancer Research. 2005, 7: R719-R727. 10.1186/bcr1279.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© BioMed Central Ltd 2006

Advertisement